English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#cabalettabio search results

Phacilitate's profile picture. Leading members network for life science executives and investment professionals working in 🧬#AdvancedTherapies #biotech. Est. 2001
Phacilitate
 @Phacilitate
Nov 8, 2023

🆕📰 #Cellares and #CabalettaBio have partnered to evaluate #automated manufacturing on Cellares' Cell Shuttle Platform for CABA-201 #CellTherapy #GeneTherapy #Automation #AutoimmuneDiseases 👉ow.ly/nJaO50Q5q9H

0
0
0
0
107
1stOncology's profile picture. Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.
1stOncology
 @1stOncology
Jan 11, 2023

#AutolusTherapeutics Announces Collaboration with #CabalettaBio for Use of Autolus’ Safety Switch System in #CellTherapies for #AutoimmuneDisease $AUTL 1stoncology.com/blog/autolus-t…

0
0
0
0
152
Chris___Nowak's profile picture. MD (Oxford), PhD (Uppsala); former Assistant Professor at Karolinska Institutet. Chief Medical and Business Officer.
Christoph Nowak
 @Chris___Nowak
Feb 26, 2023

Apropos $CABA #CabalettaBio Pivot transaction case study? Source: Torreya biopharm sector update 20 feb 23

Chris___Nowak's tweet image. Apropos $CABA #CabalettaBio Pivot transaction case study? Source: Torreya biopharm sector update 20 feb 23
Chris___Nowak's tweet image. Apropos $CABA #CabalettaBio Pivot transaction case study? Source: Torreya biopharm sector update 20 feb 23
Chris___Nowak's tweet image. Apropos $CABA #CabalettaBio Pivot transaction case study? Source: Torreya biopharm sector update 20 feb 23
0
0
0
1
586
MarketChmln's profile picture. Marker Chameleon - Instant updates STOCK MOVES | EARNINGS | NEWS
Chameleon 🦎
@MarketChmln
Jun 20, 2023

$CABA #CabalettaBio declines in after hours trading. See vwap price action. marketchameleon.com/Overview/CABA/…

MarketChmln's tweet image. $CABA #CabalettaBio declines in after hours trading. See vwap price action. marketchameleon.com/Overview/CABA/…
0
0
0
0
375
gtrades31's profile picture. 📈 Real-Time Market Updates, News, Data, Charts, Flow & More • Tweets are IMO, not Buy/Sell Advice
Gtrades
 @gtrades31
Feb 17, 2023

$CABA Reiterates a Buy 🔼 $ 11 PT At HC Wainwright & Co.; sees 41% Upside #CabalettaBio #AnalystRatings

0
0
0
0
30
ProfWhitmoreBio's profile picture. Professor of Immunology | Exploring CAR-T & autoimmune breakthroughs | Tracking #CABA and next-gen immune engineering
AlexWhitmorePhD
 @ProfWhitmoreBio
Oct 8

As an immunogenetics consultant, it’s clear that #CabalettaBio’s rese-cel (CAR-T) marks a true breakthrough in lupus therapy — complete removal of autoreactive B cells and durable immune reset. The data strongly point to a definitive success in immune reprogramming

0
2
1
0
129
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jun 17, 2023

$CABA vs. $PDSB: what is the best stock to add to your portfolio? #CabalettaBio srnk.us/go/4734257

Tickeron's tweet image. $CABA vs. $PDSB: what is the best stock to add to your portfolio? #CabalettaBio srnk.us/go/4734257
0
0
0
0
201
PharmaMfg's profile picture. Pharma Manufacturing's magazine, website & newsletters are the industry's voice for drug mfging excellence. Our editor: @Slabodkin
Pharma Manufacturing
 @PharmaMfg
Mar 19, 2025

Cellares announced that it has successfully completed a TAP using its automated cell therapy manufacturing Cell Shuttle for Cabaletta Bio’s lead clinical candidate rese-cel. Read more pharmamanufacturing.com/industry-news/… #Cellares #CabalettaBio #celltherapy #pharmanews #pharmamanufacturing

PharmaMfg's tweet card. The companies in a proof of concept automated the cellular drug substance manufacturing process for Cabaletta Bio’s CAR T-cell therapy candidate.
Cellares, Cabaletta successfully demonstrate automated cell therapy manufacturing
Source: pharmamanufacturing.com
0
0
0
0
154
Phacilitate's profile picture. Leading members network for life science executives and investment professionals working in 🧬#AdvancedTherapies #biotech. Est. 2001
Phacilitate
 @Phacilitate
Oct 4, 2023

🆕⚛️ #CabalettaBio has announced that the #FDA has cleared its #INDApplication for #SystemicSclerosis and plans to initiate a Phase I/II study. Read more here: ow.ly/OQq850PSUEQ

0
0
2
0
82
BiologyMusings's profile picture. Numbers geek with a knack for biology! Follow for data-driven tales that won't induce yawns.
Biology Deconstructed
 @BiologyMusings
Feb 13, 2024

The cell therapy landscape in the autoimmune space is led by @KyvernaT and @CabalettaBio. Both targeting Lupus with CD19 CAR-T. Both are trading @ ~$1B --> investors are expecting similar success. Stay tuned for future updates CAR-T #autoimmunediseases #Kyverna #CabalettaBio

0
0
1
0
154
MarketChmln's profile picture. Marker Chameleon - Instant updates STOCK MOVES | EARNINGS | NEWS
Chameleon 🦎
@MarketChmln
May 17, 2023

$CABA #CabalettaBio declines in after hours trading. See the latest news. marketchameleon.com/Overview/CABA/…

MarketChmln's tweet image. $CABA #CabalettaBio declines in after hours trading. See the latest news. marketchameleon.com/Overview/CABA/…
0
0
0
0
265
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
May 25, 2023

How will this affect the market? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4675745

Tickeron's tweet image. How will this affect the market? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4675745
0
0
0
0
82
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jun 13, 2023

If you have $CABA or $PDSB in your portfolio, pay attention! #CabalettaBio srnk.us/go/4723679

Tickeron's tweet image. If you have $CABA or $PDSB in your portfolio, pay attention! #CabalettaBio srnk.us/go/4723679
0
0
0
0
252
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
May 24, 2023

This is amazing! What do you think? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4674782

Tickeron's tweet image. This is amazing! What do you think? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4674782
0
0
0
0
101
HottestStockNow's profile picture. CRWEWorld's Hottest Stocks Now provides information only. It is not meant to be a recommendation/offer to buy or to sell securities. DYODD
Hottest Stocks Now
 @HottestStockNow
Jun 11

Cabaletta Bio Reveals Proposed Public Offering of Securities $CABA, #CabalettaBio, #Cabaletta crweworld.com/article/news-p…

0
0
0
0
205
HottestStockNow's profile picture. CRWEWorld's Hottest Stocks Now provides information only. It is not meant to be a recommendation/offer to buy or to sell securities. DYODD
Hottest Stocks Now
 @HottestStockNow
Jun 11

Cabaletta Bio Reveals New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma $CABA, #CabalettaBio, #Cabaletta, #Myositis, #Lupus, #Scleroderma crweworld.com/article/news-p…

0
0
0
0
159
PharmaMfg's profile picture. Pharma Manufacturing's magazine, website & newsletters are the industry's voice for drug mfging excellence. Our editor: @Slabodkin
Pharma Manufacturing
 @PharmaMfg
Mar 19, 2025

Cellares announced that it has successfully completed a TAP using its automated cell therapy manufacturing Cell Shuttle for Cabaletta Bio’s lead clinical candidate rese-cel. Read more pharmamanufacturing.com/industry-news/… #Cellares #CabalettaBio #celltherapy #pharmanews #pharmamanufacturing

PharmaMfg's tweet card. The companies in a proof of concept automated the cellular drug substance manufacturing process for Cabaletta Bio’s CAR T-cell therapy candidate.
Cellares, Cabaletta successfully demonstrate automated cell therapy manufacturing
Source: pharmamanufacturing.com
0
0
0
0
154
HottestStockNow's profile picture. CRWEWorld's Hottest Stocks Now provides information only. It is not meant to be a recommendation/offer to buy or to sell securities. DYODD
Hottest Stocks Now
 @HottestStockNow
Nov 18, 2024

Cabaletta Bio: New and updated clinical data on CABA-201 show potential to achieve drug-free, compelling clinical responses based on eight patients dosed across ongoing Phase 1/2 RESET-Myositis, RESET-SLE and RESET-SSc clinical trials $CABA, #CabalettaBio crweworld.com/article/news-p…

0
0
0
0
544
ComphiesTees's profile picture. Serving up good vibes and relatable moments! Fun, quirky, and here to keep things light and lively. Let’s laugh and connect!
Comphies
@ComphiesTees
Aug 28, 2024

#CabalettaBio Cabaletta Bio to Participate in Upcoming Investor Conferences in September: PHILADELPHIA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the… dlvr.it/TCTM8D

0
0
0
0
54
ComphiesTees's profile picture. Serving up good vibes and relatable moments! Fun, quirky, and here to keep things light and lively. Let’s laugh and connect!
Comphies
@ComphiesTees
Aug 8, 2024

#CabalettaBio Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update: – Nine patients enrolled as of August 5, 2024 across the RESET™ clinical development program, including four since EULAR in June, with 22 U.S.… dlvr.it/TBfdlv

0
0
0
0
108
HottestStockNow's profile picture. CRWEWorld's Hottest Stocks Now provides information only. It is not meant to be a recommendation/offer to buy or to sell securities. DYODD
Hottest Stocks Now
 @HottestStockNow
Jun 14, 2024

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis and RESET-SLE Trials of CABA-201 $CABA, #CabalettaBio crweworld.com/article/news-p…

0
0
1
0
204
ComphiesTees's profile picture. Serving up good vibes and relatable moments! Fun, quirky, and here to keep things light and lively. Let’s laugh and connect!
Comphies
@ComphiesTees
Jun 14, 2024

#CabalettaBio Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201 globenewswire.com/news-release/2…

0
0
0
0
64
ComphiesTees's profile picture. Serving up good vibes and relatable moments! Fun, quirky, and here to keep things light and lively. Let’s laugh and connect!
Comphies
@ComphiesTees
May 15, 2024

#CabalettaBio Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update globenewswire.com/news-release/2…

0
0
0
0
26
MarketsDotNews's profile picture. See the news as it happens. Stocks, options, crypto. Not financial advice. See terms for details. For fastest news and financial software: https://t.co/1l8aaJ7S5o
Markets News
@MarketsDotNews
Mar 21, 2024

Cabaletta Bio (NASDAQ: $CABA) announced Q4 earnings, reporting EPS of $-0.46, falling short of estimates by -18.0%. Stay informed with @Benzinga. #CabalettaBio #NASDAQ #earnings

0
0
0
0
399
ComphiesTees's profile picture. Serving up good vibes and relatable moments! Fun, quirky, and here to keep things light and lively. Let’s laugh and connect!
Comphies
@ComphiesTees
Mar 21, 2024

#CabalettaBio Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update globenewswire.com/news-release/2…

1
0
0
0
31
Chris___Nowak's profile picture. MD (Oxford), PhD (Uppsala); former Assistant Professor at Karolinska Institutet. Chief Medical and Business Officer.
Christoph Nowak
 @Chris___Nowak
Feb 26, 2023

Apropos $CABA #CabalettaBio Pivot transaction case study? Source: Torreya biopharm sector update 20 feb 23

Chris___Nowak's tweet image. Apropos $CABA #CabalettaBio Pivot transaction case study? Source: Torreya biopharm sector update 20 feb 23
Chris___Nowak's tweet image. Apropos $CABA #CabalettaBio Pivot transaction case study? Source: Torreya biopharm sector update 20 feb 23
Chris___Nowak's tweet image. Apropos $CABA #CabalettaBio Pivot transaction case study? Source: Torreya biopharm sector update 20 feb 23
0
0
0
1
586
MarketChmln's profile picture. Marker Chameleon - Instant updates STOCK MOVES | EARNINGS | NEWS
Chameleon 🦎
@MarketChmln
Jun 20, 2023

$CABA #CabalettaBio declines in after hours trading. See vwap price action. marketchameleon.com/Overview/CABA/…

MarketChmln's tweet image. $CABA #CabalettaBio declines in after hours trading. See vwap price action. marketchameleon.com/Overview/CABA/…
0
0
0
0
375
MarketChmln's profile picture. Marker Chameleon - Instant updates STOCK MOVES | EARNINGS | NEWS
Chameleon 🦎
@MarketChmln
May 17, 2023

$CABA #CabalettaBio declines in after hours trading. See the latest news. marketchameleon.com/Overview/CABA/…

MarketChmln's tweet image. $CABA #CabalettaBio declines in after hours trading. See the latest news. marketchameleon.com/Overview/CABA/…
0
0
0
0
265
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Apr 29, 2023

A.I.dvisor made a bullish call on $CABA, netting in a 28.47% gain over 3 days #CabalettaBio srnk.us/go/4613908

Tickeron's tweet image. A.I.dvisor made a bullish call on $CABA, netting in a 28.47% gain over 3 days #CabalettaBio srnk.us/go/4613908
0
0
0
0
90
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jun 17, 2023

$CABA vs. $PDSB: what is the best stock to add to your portfolio? #CabalettaBio srnk.us/go/4734257

Tickeron's tweet image. $CABA vs. $PDSB: what is the best stock to add to your portfolio? #CabalettaBio srnk.us/go/4734257
0
0
0
0
201
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
May 25, 2023

How will this affect the market? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4675745

Tickeron's tweet image. How will this affect the market? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4675745
0
0
0
0
82
elsollatinonews's profile picture. 🌐 Noticias de interés para latinos de la costa este de #EEUU ⠀⏹️ Facebook e Instagram @ elsollatinonews
El Sol Latino Newspaper
 @elsollatinonews
Sep 8, 2023

Cabaletta Bio se ha posicionado en el puesto 20 de los 100 mejores lugares de trabajo pequeños a nivel nacional en Fortune Best Small Workplaces 2023. ¡Felicidades a esta empresa de terapia celular líder en el sector biotecnológico y farmacéutico! 🎉💼 #CabalettaBio #ElSolLatino

elsollatinonews's tweet image. Cabaletta Bio se ha posicionado en el puesto 20 de los 100 mejores lugares de trabajo pequeños a nivel nacional en Fortune Best Small Workplaces 2023. ¡Felicidades a esta empresa de terapia celular líder en el sector biotecnológico y farmacéutico! 🎉💼 #CabalettaBio #ElSolLatino
0
0
0
0
14
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
May 18, 2023

Wow this is a big change! $CABA entered a Downtrend because Momentum Indicator dropped below the 0 level. #CabalettaBio srnk.us/go/4657635

Tickeron's tweet image. Wow this is a big change! $CABA entered a Downtrend because Momentum Indicator dropped below the 0 level. #CabalettaBio srnk.us/go/4657635
0
0
0
0
40
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jun 20, 2023

$CABA vs. $PDSB: what is the best stock to add to your portfolio? #CabalettaBio srnk.us/go/4744140

Tickeron's tweet image. $CABA vs. $PDSB: what is the best stock to add to your portfolio? #CabalettaBio srnk.us/go/4744140
0
0
0
0
548
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
May 2, 2023

$CABA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: srnk.us/go/4620243 #CabalettaBio

Tickeron's tweet image. $CABA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: srnk.us/go/4620243 #CabalettaBio
0
0
0
0
69
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Apr 30, 2023

Does this make you nervous? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4614944

Tickeron's tweet image. Does this make you nervous? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4614944
0
0
0
0
70
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jun 28, 2023

This is amazing! What do you think? $CABA entered a Downtrend because Momentum Indicator dropped below the 0 level. #CabalettaBio srnk.us/go/4763494

Tickeron's tweet image. This is amazing! What do you think? $CABA entered a Downtrend because Momentum Indicator dropped below the 0 level. #CabalettaBio srnk.us/go/4763494
0
0
0
0
46
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jun 13, 2023

If you have $CABA or $PDSB in your portfolio, pay attention! #CabalettaBio srnk.us/go/4723679

Tickeron's tweet image. If you have $CABA or $PDSB in your portfolio, pay attention! #CabalettaBio srnk.us/go/4723679
0
0
0
0
252
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Jun 6, 2023

Is this good for your portfolio? $CABA entered Uptrend as Momentum indicator ascends above 0 level. #CabalettaBio srnk.us/go/4706309

Tickeron's tweet image. Is this good for your portfolio? $CABA entered Uptrend as Momentum indicator ascends above 0 level. #CabalettaBio srnk.us/go/4706309
0
0
0
0
101
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
Apr 30, 2023

Wow this is a big change! $CABA RSI Indicator left the overbought zone. #CabalettaBio srnk.us/go/4616692

Tickeron's tweet image. Wow this is a big change! $CABA RSI Indicator left the overbought zone. #CabalettaBio srnk.us/go/4616692
0
0
0
0
71
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
May 8, 2023

A.I.dvisor made a bullish call on $CABA, netting in a 51.39% gain over 1 month #CabalettaBio srnk.us/go/4637275

Tickeron's tweet image. A.I.dvisor made a bullish call on $CABA, netting in a 51.39% gain over 1 month #CabalettaBio srnk.us/go/4637275
0
0
0
0
51
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
May 12, 2023

How does this make you feel? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4647315

Tickeron's tweet image. How does this make you feel? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4647315
0
0
0
0
46
Tickeron's profile picture. AI-Market Insights, Developing Financial Learning Models (FLMs) for AI Agents and helping traders profit from the stock market.
Tickeron
@Tickeron
May 24, 2023

This is amazing! What do you think? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4674782

Tickeron's tweet image. This is amazing! What do you think? $CABA Aroon Indicator entered an Uptrend. #CabalettaBio srnk.us/go/4674782
0
0
0
0
101

Something went wrong.


Something went wrong.


United States Trends